Prior to that, she served in several roles at Lutonix (acquired by CR Bard), a medical device company, from January 2010 to February 2012, including as Executive Vice President, and as Chief Business Officer of AccessClosure (acquired by Cardinal Health), a medical device company, from September 2006 to June 2009. She joined the company from Warburg Pincus, a private equity firm, where she was an Executive in Residence from March 2012 to March 2014. Leslie has served as our Chief Executive Officer since November 2014 and was elected Chair in 2022.
![outset medical jobs outset medical jobs](https://www.outsetmedical.com/wp-content/uploads/David-1920-e1624296086790.jpg)
Responsibilities included global medical affairs, clinical development, health economics, and scientific and clinical input for new product development and product life cycle management. During a nine-year tenure at Baxter, she held a number of senior leadership roles within the Renal as well as the Specialty Pharma therapeutic areas. Prichard was recruited to Baxter Healthcare as Global Vice President for Medical and Scientific Affairs in the Renal business. She published and taught widely with a focus on peritoneal dialysis and cardiovascular disease. At McGill she was a Professor of Medicine, served as Associate Dean for the Faculty of Medicine and became President of the Canadian Society of Nephrology (1997-2000) and the International Society for Peritoneal Dialysis (2001-2004). She joined the faculty of McGill University in 1979 and remained there until 2005. Prichard received her MD from Queens University at Kingston and then completed her training in Internal Medicine and Nephrology at McGill University. Currently, she serves on various corporate boards, on Scientific Advisory Boards and as a consultant. Prichard has had an academic career at McGill University, Montreal Canada, followed by a career in industry at Baxter Healthcare. Chertow has an active clinical practice focused on inpatient and outpatient nephrology care.ĭr. In addition to his research and teaching activities, Dr. Chertow has designed and/ or monitored several NIH- and industry-sponsored cohort studies and clinical trials in kidney disease, including CRIC, ATN, FHN, DAC, SPRINT, TREAT, ADVANCE and EVOLVE. He has served as an Advisor to MedPAC, for issues related to dialysis care. He also serves on the editorial boards of the Journal of the American Society of Nephrology (JASN) and Clinical Journal of the American Society of Nephrology (CJASN). He is Co-Editor of Brenner and Rector’s The Kidney, a leading nephrology textbook. and on the Scientific Advisory Board of DaVita Clinical Research. He serves on the Board of Directors for Satellite Healthcare, Inc.
![outset medical jobs outset medical jobs](https://media.glassdoor.com/lst2x/ec/04/bc/c3/packing-brown-bag-lunches.jpg)
Chertow is involved in research sponsored by the National Institutes of Health and has written numerous papers on end-stage renal disease, acute renal failure, nutrition, mineral metabolism, and the costs and outcomes of dialysis therapy.
![outset medical jobs outset medical jobs](https://static01.nyt.com/images/2020/03/24/opinion/24LevitinKhanna/merlin_170544678_6512753a-1e15-4a27-8b9a-b5b91aa45950-threeByTwoSmallAt2X.jpg)
His research interests are focused on epidemiology, health services research, and clinical trials in acute and chronic kidney disease. Coplon/ Satellite Healthcare Professor of Medicine and Chief, Division of Nephrology at Stanford School of Medicine. Alvarez devotes his time at the Palo Alto Medical Foundation working on integration of clinical services across divisions with the formation of medical service lines andĭevelopment of shared risk models of payment reform.ĭr. While maintaining a clinical practice, Dr. Alvarez works as a Medical Director for Satellite Dialysis and Wellbound Home Dialysis where he is active on the Medical Policy Committee. In this capacity he also serves as a consultant to Satellite Dialysis acute care services. Alvarez remains committed to the application of industrial continuous quality improvement concepts to the field of nephrology, including transformation of the acute renal failure care model both in the intensive unit and sub-acute hospital settings. A former advisor to the Stanford Biodesign Department, Dr. Following his doctoral work in biophysics, he worked in the pharmaceutical and device industries. Alvarez serves as Outset’s Chief Technology and Innovation Advisor, and is currently the Chair of Nephrology at the Palo Alto Medical Foundation, Sutter Health.